Silverarc Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-233,281
| Closed | -$1.36M | – | 74 |
|
|
2024
Q4 | $1.36M | Sell |
233,281
-221,801
| -49% | -$1.29M | 0.3% | 49 |
|
|
2024
Q3 | $5.43M | Sell |
455,082
-91,781
| -17% | -$1.1M | 1.22% | 28 |
|
|
2024
Q2 | $5.92M | Buy |
546,863
+31,546
| +6% | +$341K | 1.4% | 24 |
|
|
2024
Q1 | $5.83M | Sell |
515,317
-58,513
| -10% | -$662K | 1.62% | 24 |
|
|
2023
Q4 | $8.05M | Buy |
573,830
+166,029
| +41% | +$2.33M | 2.4% | 12 |
|
|
2023
Q3 | $5.04M | Buy |
407,801
+17,335
| +4% | +$214K | 1.53% | 24 |
|
|
2023
Q2 | $3.53M | Buy |
+390,466
| New | +$3.53M | 1.09% | 27 |
|